» Articles » PMID: 3299680

Immunological Properties of Antigen 60 of BCG. Induction of Humoral and Cellular Immune Reactions

Overview
Journal Scand J Immunol
Date 1987 Jun 1
PMID 3299680
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Antigen 60 (A60), a member of the thermostable macromolecular antigen family (TMA) and main component of old tuberculin and purified protein derivative (PPD), has been purified from the cytoplasm of Mycobacterium bovis BCG; its structure and metabolism have already been described. In the present paper, the action of A60 on humoral immunity has been analysed by an ELISA type immunoassay, and that on cellular immunity by the mouse footpad swelling test. Injection of very low A60 doses into unprimed mice produced an undetectable level of anti-A60 antibodies; the effect of a booster inoculation was not appreciable in the absence of incomplete Freund's adjuvant, but was evident when the latter was added. Higher doses of the antigen produced an appreciable primary response, and a sharp and long-lasting secondary response, which had a 10-fold higher intensity in the presence of incomplete adjuvant. No detectable delayed hypersensitivity reactions were observed in unprimed mice after footpad injection of A60, whereas clear responses were elicited in primed mice. This effect was more pronounced when the footpad was injected after a secondary response than after a primary response, and it was invariably magnified by incomplete adjuvant. It is concluded that A60 is a powerful immunogen, which is able to induce primary and secondary responses and delayed hypersensitivity reactions, effects that are adjuvant-modulated and develop concurrently.

Citing Articles

Proteomic Analysis of Antigen 60 Complex of Bacillus Calmette-Guérin Reveals Presence of Extracellular Vesicle Proteins and Predicted Functional Interactions.

Mohd Hanafiah K, Arifin N, Sanders P, Othman N, Garcia M, Anderson D Vaccines (Basel). 2019; 7(3).

PMID: 31382538 PMC: 6789874. DOI: 10.3390/vaccines7030080.


In vitro analysis of cancer prevention by a mycobacterial antigen complex and of cancer-promoted inhibition of immune reactions.

Maes H, Cocito C J Cancer Res Clin Oncol. 1996; 122(12):727-34.

PMID: 8954170 DOI: 10.1007/BF01209120.


Comparison between bacillus Calmette-Guérin and the A60 mycobacterial antigen complex used as cancer-preventive immunotherapies.

Maes H, Taper H, Cocito C J Cancer Res Clin Oncol. 1996; 122(5):296-300.

PMID: 8609153 DOI: 10.1007/BF01261406.


Comparative cutaneous testing with purified protein derivative and the antigen complex A60 in vaccinated subjects and tuberculosis patients.

Zou Y, Zhang J, Chen M, Shi G, Cocito C Med Microbiol Immunol. 1995; 184(1):9-15.

PMID: 8538579 DOI: 10.1007/BF00216784.


Antibodies to antigen A60 in cerebrospinal fluid from patients with tuberculous meningitis.

Lopez-Cortes L, Gomez-Mateos J, Jimenez-Mejias E, Pachon-Diaz J Eur J Clin Microbiol Infect Dis. 1994; 13(6):490-5.

PMID: 7957269 DOI: 10.1007/BF01974639.